Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A pilot multisite study of patient navigation for pregnant women with opioid use disorder.

Cochran G, Smid MC, Krans EE, Bryan MA, Gordon AJ, Lundahl B, Silipigni J, Haaland B, Tarter R.

Contemp Clin Trials. 2019 Nov 12;87:105888. doi: 10.1016/j.cct.2019.105888. [Epub ahead of print]

PMID:
31731006
2.

Pain, Opioids, and Pregnancy: Historical Context and Medical Management.

Martin CE, Terplan M, Krans EE.

Clin Perinatol. 2019 Dec;46(4):833-847. doi: 10.1016/j.clp.2019.08.013. Epub 2019 Aug 22. Review.

PMID:
31653311
3.

The intersection of intimate partner violence and substance use among women with opioid use disorder.

Pallatino C, Chang JC, Krans EE.

Subst Abus. 2019 Oct 22:1-8. doi: 10.1080/08897077.2019.1671296. [Epub ahead of print]

PMID:
31638868
4.

Opioid-related hospitalizations in Pennsylvania: A latent class analysis.

Liu SJ, Mair C, Songer TJ, Krans EE, Wahed A, Talbott E.

Drug Alcohol Depend. 2019 Sep 1;202:185-190. doi: 10.1016/j.drugalcdep.2019.05.009. Epub 2019 Jul 19.

PMID:
31352309
5.

National Partnership for Maternal Safety: Consensus Bundle on Obstetric Care for Women With Opioid Use Disorder.

Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S, Leffert LR, Main EK, Mitchell KT, OʼGurek DT, DʼOria R, McDaniel D, Terplan M.

Obstet Gynecol. 2019 Aug;134(2):365-375. doi: 10.1097/AOG.0000000000003381.

PMID:
31306323
6.

Reply.

Hollander MAG, Jarlenski MP, Krans EE.

Am J Obstet Gynecol. 2019 Oct;221(4):372. doi: 10.1016/j.ajog.2019.07.006. Epub 2019 Jul 5. No abstract available.

PMID:
31283903
7.

Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.

Krans EE, Kim JY, James AE 3rd, Kelley D, Jarlenski MP.

Obstet Gynecol. 2019 May;133(5):943-951. doi: 10.1097/AOG.0000000000003231.

PMID:
30969219
8.

The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder.

Patton BP, Krans EE, Kim JY, Jarlenski M.

Subst Abus. 2019;40(3):371-377. doi: 10.1080/08897077.2019.1573209. Epub 2019 Mar 25.

PMID:
30908175
9.

Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.

Hollander MAG, Jarlenski MP, Donohue JM, Cole ES, Kelley D, Krans EE.

Am J Obstet Gynecol. 2019 May;220(5):502-503. doi: 10.1016/j.ajog.2019.01.226. Epub 2019 Jan 28. No abstract available.

PMID:
30703340
10.

In Reply.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 Oct;132(4):1061-1062. doi: 10.1097/AOG.0000000000002885. No abstract available.

PMID:
30247340
11.

Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.

Lo-Ciganic WH, Donohue JM, Kim JY, Krans EE, Jones BL, Kelley D, James AE, Jarlenski MP.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):80-89. doi: 10.1002/pds.4647. Epub 2018 Sep 7.

PMID:
30192041
12.

Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.

Kotha A, Chen BA, Lewis L, Dunn S, Himes KP, Krans EE.

Contraception. 2019 Jan;99(1):36-41. doi: 10.1016/j.contraception.2018.08.008. Epub 2018 Aug 13.

PMID:
30114393
13.

The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.

Krans EE, Bobby S, England M, Gedekoh RH, Chang JC, Maguire B, Genday P, English DH.

Addict Behav. 2018 Nov;86:124-129. doi: 10.1016/j.addbeh.2018.05.016. Epub 2018 May 24.

PMID:
29884421
14.

Hepatitis C Virus Screening Among Children Exposed During Pregnancy.

Chappell CA, Hillier SL, Crowe D, Meyn LA, Bogen DL, Krans EE.

Pediatrics. 2018 Jun;141(6). pii: e20173273. doi: 10.1542/peds.2017-3273. Epub 2018 May 2.

15.

Opioid Detoxification During Pregnancy: A Systematic Review.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 May;131(5):803-814. doi: 10.1097/AOG.0000000000002562.

16.

Unintended hysterotomy extension during caesarean delivery: risk factors and maternal morbidity.

Giugale LE, Sakamoto S, Yabes J, Dunn SL, Krans EE.

J Obstet Gynaecol. 2018 Nov;38(8):1048-1053. doi: 10.1080/01443615.2018.1446421. Epub 2018 Mar 22.

17.

Hepatitis C Virus Knowledge Among Pregnant Women with Opioid Use Disorder.

Krans EE, Rothenberger SD, Morrison PK, Park SY, Klocke LC, Turocy MJ, Zickmund S.

Matern Child Health J. 2018 Aug;22(8):1208-1216. doi: 10.1007/s10995-018-2506-1.

18.

Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder.

Krans EE, Kim JY, James AE 3rd, Kelley DK, Jarlenski M.

Drug Alcohol Depend. 2018 Apr 1;185:207-213. doi: 10.1016/j.drugalcdep.2017.12.023. Epub 2018 Feb 14.

19.

Filled Prescriptions for Opioids After Vaginal Delivery.

Jarlenski M, Bodnar LM, Kim JY, Donohue J, Krans EE, Bogen DL.

Obstet Gynecol. 2017 Mar;129(3):431-437. doi: 10.1097/AOG.0000000000001868.

20.

The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.

Pryor JR, Maalouf FI, Krans EE, Schumacher RE, Cooper WO, Patrick SW.

Arch Dis Child Fetal Neonatal Ed. 2017 Mar;102(2):F183-F187. doi: 10.1136/archdischild-2015-310045. Epub 2017 Jan 10. Review.

21.

In Reply.

Krans EE, Patrick SW.

Obstet Gynecol. 2016 Nov;128(5):1180-1181. No abstract available.

PMID:
27776057
22.

In Reply.

Krans EE, Patrick SW.

Obstet Gynecol. 2016 Nov;128(5):1179-1180. No abstract available.

PMID:
27776055
23.

Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.

Krans EE, Patrick SW.

Obstet Gynecol. 2016 Jul;128(1):4-10. doi: 10.1097/AOG.0000000000001446. Review.

24.

Factors associated with buprenorphine versus methadone use in pregnancy.

Krans EE, Bogen D, Richardson G, Park SY, Dunn SL, Day N.

Subst Abus. 2016 Oct-Dec;37(4):550-557. Epub 2016 Feb 25.

25.

Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.

Krans EE, Zickmund SL, Rustgi VK, Park SY, Dunn SL, Schwarz EB.

Subst Abus. 2016;37(1):88-95. doi: 10.1080/08897077.2015.1118720. Epub 2015 Nov 16.

26.

Surgical Site Infection following Cesarean Delivery: Patient, Provider, and Procedure-Specific Risk Factors.

Shree R, Park SY, Beigi RH, Dunn SL, Krans EE.

Am J Perinatol. 2016 Jan;33(2):157-64. doi: 10.1055/s-0035-1563548. Epub 2015 Sep 7.

27.

Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations.

Krans EE, Cochran G, Bogen DL.

Clin Obstet Gynecol. 2015 Jun;58(2):370-9. doi: 10.1097/GRF.0000000000000098.

28.

Strong Start for Mothers and Newborns: implications for prenatal care delivery.

Krans EE, Davis MM.

Curr Opin Obstet Gynecol. 2014 Dec;26(6):511-5. doi: 10.1097/GCO.0000000000000118. Review.

29.

Impact of psychosocial risk factors on prenatal care delivery: a national provider survey.

Krans EE, Moloci NM, Housey MT, Davis MM.

Matern Child Health J. 2014 Dec;18(10):2362-70. doi: 10.1007/s10995-014-1476-1.

30.

In reply.

Bradley MS, Krans EE.

Obstet Gynecol. 2014 Feb;123(2 Pt 1):361-2. doi: 10.1097/AOG.0000000000000111. No abstract available.

PMID:
24451663
31.

Effect of rotation on perineal lacerations in forceps-assisted vaginal deliveries.

Bradley MS, Kaminski RJ, Streitman DC, Dunn SL, Krans EE.

Obstet Gynecol. 2013 Jul;122(1):132-7. doi: 10.1097/AOG.0b013e31829752fc.

32.

Psychosocial risk, prenatal counseling and maternal behavior: findings from PRAMS, 2004-2008.

Krans EE, Davis MM, Schwarz EB.

Am J Obstet Gynecol. 2013 Feb;208(2):141.e1-7. doi: 10.1016/j.ajog.2012.11.017. Epub 2012 Nov 15.

PMID:
23159699
33.

Disparate patterns of prenatal care utilization stratified by medical and psychosocial risk.

Krans EE, Davis MM, Palladino CL.

Matern Child Health J. 2013 May;17(4):639-45. doi: 10.1007/s10995-012-1040-9.

PMID:
22581379
34.

Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM.

JAMA. 2012 May 9;307(18):1934-40. doi: 10.1001/jama.2012.3951. Epub 2012 Apr 30.

PMID:
22546608
35.

A will without a way: barriers and facilitators to exercise during pregnancy of low-income, African American women.

Krans EE, Chang JC.

Women Health. 2011 Nov 30;51(8):777-94. doi: 10.1080/03630242.2011.633598.

PMID:
22185291
36.

Low-income African American women's beliefs regarding exercise during pregnancy.

Krans EE, Chang JC.

Matern Child Health J. 2012 Aug;16(6):1180-7. doi: 10.1007/s10995-011-0883-9.

PMID:
21910011
37.

Preventing Low Birthweight: 25 years, prenatal risk, and the failure to reinvent prenatal care.

Krans EE, Davis MM.

Am J Obstet Gynecol. 2012 May;206(5):398-403. doi: 10.1016/j.ajog.2011.06.082. Epub 2011 Jun 29.

PMID:
21889122
38.

Pregnant women's beliefs and influences regarding exercise during pregnancy.

Krans EE, Gearhart JG, Dubbert PM, Klar PM, Miller AL, Replogle WH.

J Miss State Med Assoc. 2005 Mar;46(3):67-73.

PMID:
15822648

Supplemental Content

Loading ...
Support Center